AP NEWS
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

KOL Perspectives on Histologic Healing in Crohn’s Disease, 2018 Report - ResearchAndMarkets.com

February 21, 2019

DUBLIN--(BUSINESS WIRE)--Feb 21, 2019--The “KOL Perspectives: Histologic Healing in Crohn’s disease” drug pipelines has been added to ResearchAndMarkets.com’s offering.

This KOL Insight briefing focuses on KOLs views of Histologic Healing in Crohn’s disease.

Questions topics

Key Highlights

Scope

In total, we conducted interviews with 10 KOLs

KOL data is analyzed to produce

Reasons to Buy

Key Topics Covered:

Companies Mentioned

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/p8vr64/kol_perspectives?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190221005395/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Gastrointestinal Drugs

KEYWORD: EUROPE NORTH AMERICA

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 02/21/2019 05:22 AM/DISC: 02/21/2019 05:22 AM

http://www.businesswire.com/news/home/20190221005395/en